GSK1349572 (Dolutegravir): Mechanism of Action

GSK1349572 (Dolutegravir) MOA:Targeting HIV-1 Integrase/Viral Replication Pathway for Antiretroviral Therapy Optimization and Two-Drug Regimens

🎯 check GSK1349572 (Dolutegravir) product page

GSK1349572 (Dolutegravir) is a potent metal-chelating HIV-1 integrase inhibitor. It affects HIV-1 integration and inflammatory signaling pathways, by binding to the catalytic domain and chelating metal ions, to inhibit viral DNA strand transfer and HIV-1 replication.

Primary Applications and Mechanism of Action